Popat R - Search Results

1

Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials.

El-Sharkawi D, Ng CH, Payne EM, Yong KL, Ardeshna KM, Khwaja A, Townsend W, Popat R. El-Sharkawi D, et al. Among authors: popat r. Br J Haematol. 2019 Apr;185(2):344-347. doi: 10.1111/bjh.15457. Epub 2018 Jul 5. Br J Haematol. 2019. PMID: 29978458 Free article. Clinical Trial. No abstract available.

2

PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma.

Oakervee HE, Popat R, Curry N, Smith P, Morris C, Drake M, Agrawal S, Stec J, Schenkein D, Esseltine DL, Cavenagh JD. Oakervee HE, et al. Among authors: popat r. Br J Haematol. 2005 Jun;129(6):755-62. doi: 10.1111/j.1365-2141.2005.05519.x. Br J Haematol. 2005. PMID: 15953001 Free article. Clinical Trial.

3

Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up.

Popat R, Oakervee HE, Hallam S, Curry N, Odeh L, Foot N, Esseltine DL, Drake M, Morris C, Cavenagh JD. Popat R, et al. Br J Haematol. 2008 May;141(4):512-6. doi: 10.1111/j.1365-2141.2008.06997.x. Epub 2008 Mar 26. Br J Haematol. 2008. PMID: 18371113 Free article. Clinical Trial.

4

Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma.

Popat R, Oakervee H, Williams C, Cook M, Craddock C, Basu S, Singer C, Harding S, Foot N, Hallam S, Odeh L, Joel S, Cavenagh J. Popat R, et al. Br J Haematol. 2009 Mar;144(6):887-94. doi: 10.1111/j.1365-2141.2008.07572.x. Epub 2009 Jan 12. Br J Haematol. 2009. PMID: 19183191 Free article. Clinical Trial.

5

The histone deacetylase inhibitor UCL67022 has potent activity in multiple myeloma and non-Hodgkin lymphoma pre-clinical models.

Maharaj L, Marson CM, Middleton BJ, Rioja AS, Perry J, Oakervee H, Cavenagh J, Joel SP, Popat R. Maharaj L, et al. Among authors: popat r. Br J Haematol. 2013 Oct;163(1):135-9. doi: 10.1111/bjh.12456. Epub 2013 Jul 9. Br J Haematol. 2013. PMID: 23834265 Free article. No abstract available.

6

An alternative dosing strategy of lenalidomide for patients with relapsed multiple myeloma.

Popat R, Khan I, Dickson J, Cheesman S, Smith D, D'Sa S, Rabin N, Yong K. Popat R, et al. Br J Haematol. 2015 Jan;168(1):148-51. doi: 10.1111/bjh.13072. Epub 2014 Aug 8. Br J Haematol. 2015. PMID: 25103844 Free article. No abstract available.

7

Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapse.

Reyal Y, Popat R, Cheesman S, Rismani A, D'Sa S, Rabin N, Yong K. Reyal Y, et al. Among authors: popat r. Br J Haematol. 2017 May;177(3):495-497. doi: 10.1111/bjh.14086. Epub 2016 Apr 8. Br J Haematol. 2017. PMID: 27062387 Free article. No abstract available.

8

Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response.

Latifoltojar A, Hall-Craggs M, Rabin N, Popat R, Bainbridge A, Dikaios N, Sokolska M, Rismani A, D'Sa S, Punwani S, Yong K. Latifoltojar A, et al. Among authors: popat r. Br J Haematol. 2017 Jan;176(2):222-233. doi: 10.1111/bjh.14401. Epub 2016 Oct 21. Br J Haematol. 2017. PMID: 27766627 Free PMC article.

9

Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial.

Popat R, Brown SR, Flanagan L, Hall A, Gregory W, Kishore B, Streetly M, Oakervee H, Yong K, Cook G, Low E, Cavenagh J; Myeloma UK Early Phase Clinical Trial Network. Popat R, et al. Lancet Haematol. 2016 Dec;3(12):e572-e580. doi: 10.1016/S2352-3026(16)30165-X. Epub 2016 Nov 12. Lancet Haematol. 2016. PMID: 27843120 Free article. Clinical Trial.

10

Real-world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi-centre UK experience.

Maciocia N, Melville A, Cheesman S, Sharpley F, Ramasamy K, Streetly M, Jenner M, Benjamin R, Schey S, Maciocia P, Popat R, D'sa S, Rismani A, Cerner A, Yong K, Rabin N. Maciocia N, et al. Among authors: popat r. Br J Haematol. 2017 Mar;176(6):908-917. doi: 10.1111/bjh.14547. Epub 2017 Feb 17. Br J Haematol. 2017. PMID: 28211054 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters